Tourmaline Depreciation vs Change In Working Capital Analysis
| TRML Stock | 22.56 1.82 7.47% |
Tourmaline Bio financial indicator trend analysis is much more than just breaking down Tourmaline Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tourmaline Bio is a good investment. Please check the relationship between Tourmaline Bio Depreciation and its Change In Working Capital accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.
Depreciation vs Change In Working Capital
Depreciation vs Change In Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tourmaline Bio Depreciation account and Change In Working Capital. At this time, the significance of the direction appears to have weak relationship.
The correlation between Tourmaline Bio's Depreciation and Change In Working Capital is 0.35. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Change In Working Capital in the same time period over historical financial statements of Tourmaline Bio, assuming nothing else is changed. The correlation between historical values of Tourmaline Bio's Depreciation and Change In Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Tourmaline Bio are associated (or correlated) with its Change In Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Working Capital has no effect on the direction of Depreciation i.e., Tourmaline Bio's Depreciation and Change In Working Capital go up and down completely randomly.
Correlation Coefficient | 0.35 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Depreciation
Depreciation indicates how much of Tourmaline Bio value has been used up. For tax purposes Tourmaline Bio can deduct the cost of the tangible assets it purchases as business expenses. However, Tourmaline Bio must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Most indicators from Tourmaline Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tourmaline Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.At this time, Tourmaline Bio's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 0.37 this year, although the value of Issuance Of Capital Stock will most likely fall to about 100.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 904.0 | 19.7M | 45.4M | 23.2M | Cost Of Revenue | 623K | 6K | 33K | 31.4K |
Tourmaline Bio fundamental ratios Correlations
Click cells to compare fundamentals
Tourmaline Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.49) | Return On Assets (0.24) | Return On Equity (0.32) |
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.